Our results demonstrated that BBR significantly remodelled the gut microbiota to suppress TLR4 signalling and impaired gut barrier, which inhibited the vicious circle of NLRP3 activation and inflammatory cytokines release induced by GVHD. The gene discussed is NLRP3; the disease is graft versus host disease.